Answers are grounded in this paper and cite their sources.
Randomized skin flaps have been used as a basic treatment modality for covering skin defects for a long time but they have always been in the risk of an inherent ischemia. Fibroblast growth factor 1 is a known angiogenic factor in in vitro studies which has shown conflicting results in in vivo investigation. We aimed to determine the effect of recombinant fibroblast growth factor on the angiogenesis rate of random cutaneous flap in animal model of rats.
No takes yet. Share an insight, caveat, or question.
Akbari et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: